OR WAIT null SECS
February 01, 2012
A technical forum featuring Catalent Pharma Solutions, SAFC, and Neuland Laboratories.
December 02, 2011
Expansion activity was limited as fine-chemical producers and CMOs of API and intermediates grapple with changing industry fundamentals.
Drug shortages, supply-chain security, generic-drug incursion, and flexible manufacturing models are some of the issues shaping the bio/pharma industry.
October 02, 2011
The global excipients market shows moderate growth, increased consolidation, and expansion activity in emerging markets and select product areas.
September 02, 2011
Biocatalysis, chemocatalysis, and other chiral technologies continue to attract the investment dollars of CMOs and fine-chemical companies.
September 01, 2011
The increased trend of outsourcing coupled with a relatively strong economy has seen the fine chemicals market grow at a very high level when compared to historical data.
As contract manufacturers and fine-chemical suppliers gather for CPhI/ICSE, effective strategies for technology differentiation are key in an increasingly competitive environment.
August 01, 2011
Avantor reviews its experience with the Rx-360 shared audit pilot program, which is aimed at protecting the pharmaceutical supply chain. This article is part of a special issue on Outsourcing.
June 02, 2011
A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
April 02, 2011
Chemocatalytic and biocatalytic routes play an important role in improving the manufacture of intermediates and active pharmaceutical ingredients.